Phase 1 study

Not yet recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 15 October 2026 Not medical advice

This trial at a glance

Status Not yet recruiting
Phase Phase 1
Sponsor Ursa Medicines
Registry number NCT07864311
Started 1 November 2026 Today 16 October 2026 Estimated completion 1 September 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
University of Sunshine Coast Morayfield QLD Status not stated
Linear Clinical Research Nedlands WA Status not stated

voxsanity.com.au · trial sites from public registries · registry record synced 15 October 2026 · not medical advice

Who can join

Age 18 Years to 65 Years
Sex Anyone, regardless of sex
Healthy volunteers Accepted
Enrolment target 60

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Key Inclusion Criteria (All Parts):

* Participants must be adults able to understand the study, provide written informed consent, and comply with study procedures.

* Age: Part A: 18-55 years; Part B: 18-65 years

* BMI and body weight: Part A: BMI 18.0-30.0 kg/m²; Part B: BMI 18.0-35.0 kg/m²

* Considered medically healthy based on medical history and screening assessments.

* Male and Female participants must agree to contraception requirements.

Key Inclusion Criteria (Part B):

\- Elevated LDL-C and Lipoprotein(a)

Key Exclusion Criteria (All Parts):

* Known familial hypercholesterolemia or severe hypertriglyceridemia.

* Clinically significant cardiovascular, liver, kidney, immune, or other medical disease.

* Positive screening for HIV, hepatitis B, or hepatitis C.

* Current significant infection, substance misuse, or other condition that could interfere with study participation.

Key Exclusion Criteria (Part B):

* Uncontrolled type 2 diabetes.

* Recent changes in lipid-lowering therapy.

* History of significant cardiovascular disease, including myocardial infarction, stroke, heart failure, significant arrhythmia, or uncontrolled hypertension.

Dates on the record

Started 1 November 2026
Estimated completion 1 September 2027
Registry last updated 15 October 2026
Checked by Voxsanity 15 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 15 October 2026.
  • This page last checked by Voxsanity: 15 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.